JP2012503987A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012503987A5 JP2012503987A5 JP2011529292A JP2011529292A JP2012503987A5 JP 2012503987 A5 JP2012503987 A5 JP 2012503987A5 JP 2011529292 A JP2011529292 A JP 2011529292A JP 2011529292 A JP2011529292 A JP 2011529292A JP 2012503987 A5 JP2012503987 A5 JP 2012503987A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- retrovirus
- polynucleotide
- retroviral
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10066608P | 2008-09-26 | 2008-09-26 | |
| US61/100,666 | 2008-09-26 | ||
| US12061808P | 2008-12-08 | 2008-12-08 | |
| US61/120,618 | 2008-12-08 | ||
| US18682309P | 2009-06-13 | 2009-06-13 | |
| US61/186,823 | 2009-06-13 | ||
| PCT/US2009/058512 WO2010036986A2 (en) | 2008-09-26 | 2009-09-26 | Recombinant vectors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015004923A Division JP5992548B2 (ja) | 2008-09-26 | 2015-01-14 | 組換えベクター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012503987A JP2012503987A (ja) | 2012-02-16 |
| JP2012503987A5 true JP2012503987A5 (https=) | 2012-11-15 |
| JP5684130B2 JP5684130B2 (ja) | 2015-03-11 |
Family
ID=42060421
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011529292A Expired - Fee Related JP5684130B2 (ja) | 2008-09-26 | 2009-09-26 | 組換えベクター |
| JP2011529291A Expired - Fee Related JP5771147B2 (ja) | 2008-09-26 | 2009-09-26 | 遺伝子治療ベクターおよびシトシンデアミナーゼ |
| JP2015004923A Expired - Fee Related JP5992548B2 (ja) | 2008-09-26 | 2015-01-14 | 組換えベクター |
| JP2015097980A Expired - Fee Related JP6062485B2 (ja) | 2008-09-26 | 2015-05-13 | 遺伝子治療ベクターおよびシトシンデアミナーゼ |
| JP2016159893A Expired - Fee Related JP6523224B2 (ja) | 2008-09-26 | 2016-08-17 | 組換えベクター |
| JP2019086133A Pending JP2019141088A (ja) | 2008-09-26 | 2019-04-26 | 組換えベクター |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011529291A Expired - Fee Related JP5771147B2 (ja) | 2008-09-26 | 2009-09-26 | 遺伝子治療ベクターおよびシトシンデアミナーゼ |
| JP2015004923A Expired - Fee Related JP5992548B2 (ja) | 2008-09-26 | 2015-01-14 | 組換えベクター |
| JP2015097980A Expired - Fee Related JP6062485B2 (ja) | 2008-09-26 | 2015-05-13 | 遺伝子治療ベクターおよびシトシンデアミナーゼ |
| JP2016159893A Expired - Fee Related JP6523224B2 (ja) | 2008-09-26 | 2016-08-17 | 組換えベクター |
| JP2019086133A Pending JP2019141088A (ja) | 2008-09-26 | 2019-04-26 | 組換えベクター |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US8722867B2 (https=) |
| EP (4) | EP2346995B1 (https=) |
| JP (6) | JP5684130B2 (https=) |
| KR (3) | KR101870056B1 (https=) |
| CN (4) | CN102227503B (https=) |
| AU (1) | AU2009303690B2 (https=) |
| BR (1) | BRPI0919113A2 (https=) |
| CA (1) | CA2738472A1 (https=) |
| CO (1) | CO6362050A2 (https=) |
| DK (1) | DK2346995T3 (https=) |
| EA (2) | EA201790824A3 (https=) |
| ES (2) | ES2706899T3 (https=) |
| IL (3) | IL211847A (https=) |
| MX (3) | MX2011003039A (https=) |
| MY (1) | MY156333A (https=) |
| NZ (1) | NZ592070A (https=) |
| WO (2) | WO2010045002A2 (https=) |
| ZA (1) | ZA201102115B (https=) |
Families Citing this family (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2386646B1 (en) | 1998-10-01 | 2016-12-21 | University Of Southern California | Gene delivery system and methods of use |
| US9320738B2 (en) | 2008-06-30 | 2016-04-26 | Tocagen Inc. | Formulations of 5-fluorocytosine and uses thereof |
| CN102227503B (zh) * | 2008-09-26 | 2015-10-21 | 托卡根公司 | 重组载体 |
| US8829173B2 (en) * | 2008-09-26 | 2014-09-09 | Tocagen Inc. | Recombinant vectors |
| JP5923037B2 (ja) | 2009-06-17 | 2016-05-24 | トカジェン インコーポレーテッド | 複製可能レトロウイルスベクターの産生細胞 |
| JP2013531496A (ja) * | 2010-06-06 | 2013-08-08 | モウント シナイ スクール オフ メディシネ | 組換えｒｎａウイルス及びその使用 |
| EP2913402B1 (en) | 2010-07-16 | 2017-10-18 | Tocagen Inc. | Retrovirus detection |
| WO2012058673A2 (en) | 2010-10-31 | 2012-05-03 | Tocagen Inc. | Enhanced cancer treatment and monitoring using recombinant vectors |
| US20140178854A1 (en) | 2010-10-31 | 2014-06-26 | Tocagen Inc. | Antisera assays for mlv related viruses in humans and other mammals |
| CN107488233A (zh) * | 2011-06-02 | 2017-12-19 | 台北荣民总医院 | 治疗感染性与恶性疾病的标靶化学治疗药物的形成方法 |
| KR101554678B1 (ko) * | 2012-10-19 | 2015-09-21 | 영남대학교 산학협력단 | 식물 바이러스를 이용한 식물체 형질전환을 위한 유전자 전달 시스템 및 이의 용도 |
| ES2786051T3 (es) | 2012-10-25 | 2020-10-08 | Tocagen Inc | Vector retroviral con casete de mini-promotor |
| HK1213923A1 (zh) * | 2012-11-15 | 2016-07-15 | Esperance Pharmaceuticals, Inc. | 促卵激素(fsh)/胞溶域融合構造體和其製備及使用方法 |
| US9642921B2 (en) | 2012-12-20 | 2017-05-09 | Tocagen Inc. | Cancer combination therapy and recombinant vectors |
| ES2745103T3 (es) | 2013-06-15 | 2020-02-27 | Tocagen Inc | Partículas inmunosupresivas similares a virus basadas en gammaretrovirus |
| WO2015021077A1 (en) * | 2013-08-05 | 2015-02-12 | Tocagen Inc. | Recombinant vector with optimized a-bulge |
| CN103966260A (zh) * | 2014-03-07 | 2014-08-06 | 山东农业大学 | 一种基于J亚群禽白血病病毒pol基因保守序列的siRNA重组干扰载体及其制备方法和应用 |
| JP6894236B2 (ja) * | 2014-03-26 | 2021-06-30 | デノボ バイオファーマ エルエルシー | 免疫刺激活性を有するレトロウイルスベクター |
| US10611837B2 (en) | 2014-04-10 | 2020-04-07 | Seattle Children's Hospital | Transgene genetic tags and methods of use |
| WO2015168102A2 (en) * | 2014-04-28 | 2015-11-05 | Board Of Regents, The University Of Texas System | Prolonged protein stabilization by resveratrol |
| CN104557602B (zh) * | 2015-01-07 | 2016-08-17 | 华东师范大学 | 三环二萜衍生物及其制备方法、及其在制备抗肿瘤药物中的应用 |
| AU2016306209B2 (en) | 2015-08-07 | 2023-07-06 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Bispecific CAR T-cells for solid tumor targeting |
| JP2018526007A (ja) | 2015-09-04 | 2018-09-13 | トカジェン インコーポレーテッド | ２ａペプチドを含む組換えベクター |
| US11293021B1 (en) | 2016-06-23 | 2022-04-05 | Inscripta, Inc. | Automated cell processing methods, modules, instruments, and systems |
| GB2572716B (en) | 2016-11-29 | 2022-06-22 | Articure Co Ltd | Gene Therapy Vector System and Prodrug Genes |
| CN107058314B (zh) * | 2016-11-30 | 2020-09-04 | 暨南大学 | 一种启动子及其应用 |
| US11408005B2 (en) | 2016-12-12 | 2022-08-09 | Seattle Children's Hospital | Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells |
| US9982279B1 (en) | 2017-06-23 | 2018-05-29 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| US10011849B1 (en) | 2017-06-23 | 2018-07-03 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| JP2020530979A (ja) | 2017-06-30 | 2020-11-05 | インスクリプタ， インコーポレイテッド | 自動細胞処理方法、モジュール、機器及びシステム |
| GB201710973D0 (en) | 2017-07-07 | 2017-08-23 | Avacta Life Sciences Ltd | Scaffold proteins |
| KR20200036873A (ko) * | 2017-07-14 | 2020-04-07 | 온코루스, 인크. | 캡슐화된 폴리뉴클레오티드 및 사용 방법 |
| KR20200104371A (ko) | 2017-12-27 | 2020-09-03 | 에티컨, 엘엘씨 | 광 결핍 환경에서의 형광 이미징 |
| EP3758755A1 (en) * | 2018-02-26 | 2021-01-06 | Ablynx N.V. | Improved nucleotide sequences encoding peptide linkers |
| US10858761B2 (en) | 2018-04-24 | 2020-12-08 | Inscripta, Inc. | Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells |
| US10557216B2 (en) | 2018-04-24 | 2020-02-11 | Inscripta, Inc. | Automated instrumentation for production of T-cell receptor peptide libraries |
| CN110396504A (zh) * | 2018-04-25 | 2019-11-01 | 江苏省原子医学研究所 | 一种具有肿瘤靶向性的重组痘苗病毒及其制备方法、用途 |
| CA3108767A1 (en) | 2018-06-30 | 2020-01-02 | Inscripta, Inc. | Instruments, modules, and methods for improved detection of edited sequences in live cells |
| US11142740B2 (en) | 2018-08-14 | 2021-10-12 | Inscripta, Inc. | Detection of nuclease edited sequences in automated modules and instruments |
| US11214781B2 (en) | 2018-10-22 | 2022-01-04 | Inscripta, Inc. | Engineered enzyme |
| EP3653716A1 (en) * | 2018-11-19 | 2020-05-20 | HSF Pharmaceuticals | Replication-competent controlled alpha-herpesvirus virus vectors and uses therefore |
| US11001831B2 (en) | 2019-03-25 | 2021-05-11 | Inscripta, Inc. | Simultaneous multiplex genome editing in yeast |
| AU2020247900A1 (en) | 2019-03-25 | 2021-11-04 | Inscripta, Inc. | Simultaneous multiplex genome editing in yeast |
| AU2020288623A1 (en) | 2019-06-06 | 2022-01-06 | Inscripta, Inc. | Curing for recursive nucleic acid-guided cell editing |
| US11096565B2 (en) | 2019-06-20 | 2021-08-24 | Cilag Gmbh International | Driving light emissions according to a jitter specification in a hyperspectral, fluorescence, and laser mapping imaging system |
| US10952619B2 (en) | 2019-06-20 | 2021-03-23 | Ethicon Llc | Hyperspectral and fluorescence imaging and topology laser mapping with minimal area monolithic image sensor |
| US11266304B2 (en) | 2019-06-20 | 2022-03-08 | Cilag Gmbh International | Minimizing image sensor input/output in a pulsed hyperspectral imaging system |
| US12440085B2 (en) | 2019-06-20 | 2025-10-14 | Cilag Gmbh International | Image synchronization without input clock and data transmission clock in a pulsed laser mapping imaging system |
| US11516387B2 (en) | 2019-06-20 | 2022-11-29 | Cilag Gmbh International | Image synchronization without input clock and data transmission clock in a pulsed hyperspectral, fluorescence, and laser mapping imaging system |
| US11389066B2 (en) | 2019-06-20 | 2022-07-19 | Cilag Gmbh International | Noise aware edge enhancement in a pulsed hyperspectral, fluorescence, and laser mapping imaging system |
| US11311183B2 (en) | 2019-06-20 | 2022-04-26 | Cilag Gmbh International | Controlling integral energy of a laser pulse in a fluorescence imaging system |
| US12013496B2 (en) | 2019-06-20 | 2024-06-18 | Cilag Gmbh International | Noise aware edge enhancement in a pulsed laser mapping imaging system |
| US11944273B2 (en) | 2019-06-20 | 2024-04-02 | Cilag Gmbh International | Fluorescence videostroboscopy of vocal cords |
| US11012599B2 (en) | 2019-06-20 | 2021-05-18 | Ethicon Llc | Hyperspectral imaging in a light deficient environment |
| US11589819B2 (en) | 2019-06-20 | 2023-02-28 | Cilag Gmbh International | Offset illumination of a scene using multiple emitters in a laser mapping imaging system |
| US11237270B2 (en) | 2019-06-20 | 2022-02-01 | Cilag Gmbh International | Hyperspectral, fluorescence, and laser mapping imaging with fixed pattern noise cancellation |
| US11617541B2 (en) | 2019-06-20 | 2023-04-04 | Cilag Gmbh International | Optical fiber waveguide in an endoscopic system for fluorescence imaging |
| US12126887B2 (en) | 2019-06-20 | 2024-10-22 | Cilag Gmbh International | Hyperspectral and fluorescence imaging with topology laser scanning in a light deficient environment |
| US11280737B2 (en) | 2019-06-20 | 2022-03-22 | Cilag Gmbh International | Super resolution and color motion artifact correction in a pulsed fluorescence imaging system |
| CA3149494A1 (en) | 2019-08-12 | 2021-02-18 | Purinomia Biotech, Inc. | Methods and compositions for promoting and potentiating t-cell mediated immune responses through adcc targeting of cd39 expressing cells |
| KR102281858B1 (ko) | 2019-09-11 | 2021-07-26 | 주식회사 쎌바이오텍 | 유산균 유래 p8 단백질의 발현 컨스트럭트를 포함하는 대장 질환의 치료 또는 예방용 조성물 |
| WO2021074695A1 (en) | 2019-10-16 | 2021-04-22 | Avacta Life Sciences Limited | PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES. |
| US11203762B2 (en) | 2019-11-19 | 2021-12-21 | Inscripta, Inc. | Methods for increasing observed editing in bacteria |
| AU2020407048A1 (en) | 2019-12-18 | 2022-06-09 | Inscripta, Inc. | Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells |
| US11225674B2 (en) | 2020-01-27 | 2022-01-18 | Inscripta, Inc. | Electroporation modules and instrumentation |
| US20210332388A1 (en) | 2020-04-24 | 2021-10-28 | Inscripta, Inc. | Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells |
| GB202101299D0 (en) | 2020-06-09 | 2021-03-17 | Avacta Life Sciences Ltd | Diagnostic polypetides and methods |
| CN111944810B (zh) * | 2020-07-29 | 2022-05-27 | 中国农业大学 | 靶向敲除TNFα基因的sgRNA和敲除TNFα基因的猪胚胎成纤维细胞系及其应用 |
| US11299731B1 (en) | 2020-09-15 | 2022-04-12 | Inscripta, Inc. | CRISPR editing to embed nucleic acid landing pads into genomes of live cells |
| US11512297B2 (en) | 2020-11-09 | 2022-11-29 | Inscripta, Inc. | Affinity tag for recombination protein recruitment |
| AU2021415461A1 (en) | 2021-01-04 | 2023-08-17 | Inscripta, Inc. | Mad nucleases |
| EP4274890A4 (en) | 2021-01-07 | 2024-11-27 | Inscripta, Inc. | MAD-NUCLEASES |
| US11884924B2 (en) | 2021-02-16 | 2024-01-30 | Inscripta, Inc. | Dual strand nucleic acid-guided nickase editing |
| WO2022234003A1 (en) | 2021-05-07 | 2022-11-10 | Avacta Life Sciences Limited | Cd33 binding polypeptides with stefin a protein |
| EP4413038A1 (en) | 2021-10-07 | 2024-08-14 | Avacta Life Sciences Limited | Pd-l1 binding affimers |
| US20240409638A1 (en) | 2021-10-07 | 2024-12-12 | Avacta Life Sciences Limited | Serum half-life extended pd-l1 binding polypeptides |
| LT7046B (lt) | 2022-04-15 | 2024-02-12 | Vilniaus Universitetas | Hidrolazės ir jų panaudojimas |
| IL316289A (en) | 2022-04-29 | 2024-12-01 | Purinomia Biotech Inc | Methods and compositions for treating diseases and disorders driven by eosinophils |
| CN118697758B (zh) * | 2024-05-31 | 2025-10-21 | 河北大学 | miR-128-1-5p的应用 |
Family Cites Families (103)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4405712A (en) | 1981-07-01 | 1983-09-20 | The United States Of America As Represented By The Department Of Health And Human Services | LTR-Vectors |
| US4650764A (en) | 1983-04-12 | 1987-03-17 | Wisconsin Alumni Research Foundation | Helper cell |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| CA2018273C (en) | 1989-06-09 | 1999-04-06 | Peter D. Senter | Thermally stable cytosine deaminase |
| US5358866A (en) | 1991-07-03 | 1994-10-25 | The United States Of America As Represented By The Department Of Health And Human Services | Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| US5770428A (en) * | 1993-02-17 | 1998-06-23 | Wisconsin Alumni Research Foundation | Chimeric retrovial expression vectors and particles containing a simple retroviral long terminal repeat, BLV or HIV coding regions and cis-acting regulatory sequences, and an RNA translational enhancer with internal ribsome entry site |
| AU680508B2 (en) | 1993-04-06 | 1997-07-31 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Gibbon ape leukemia virus-based retroviral vectors |
| US5426039A (en) | 1993-09-08 | 1995-06-20 | Bio-Rad Laboratories, Inc. | Direct molecular cloning of primer extended DNA containing an alkane diol |
| EP0728195A1 (en) | 1993-10-12 | 1996-08-28 | Chiron Corporation | Methods for preserving recombinant viruses |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| US5834252A (en) | 1995-04-18 | 1998-11-10 | Glaxo Group Limited | End-complementary polymerase reaction |
| JP4046349B2 (ja) | 1994-11-07 | 2008-02-13 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | 腫瘍壊死因子−γ |
| US20030157070A1 (en) | 1994-12-30 | 2003-08-21 | Jolly Douglas J. | High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations |
| US6117681A (en) | 1995-03-29 | 2000-09-12 | Bavarian Nordic Research Inst. A/S | Pseudotyped retroviral particles |
| JPH11507205A (ja) | 1995-04-27 | 1999-06-29 | ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド | ヒト腫瘍壊死因子受容体 |
| US20030026789A1 (en) | 1995-05-03 | 2003-02-06 | Richard J. Gregory | Gene therapy using replication competent targeted adenoviral vectors |
| WO1997033904A1 (en) | 1996-03-12 | 1997-09-18 | Human Genome Sciences, Inc. | Death domain containing receptors |
| AU5711196A (en) | 1996-03-14 | 1997-10-01 | Human Genome Sciences, Inc. | Apoptosis inducing molecule i |
| US6096548A (en) | 1996-03-25 | 2000-08-01 | Maxygen, Inc. | Method for directing evolution of a virus |
| ES2308787T3 (es) | 1996-08-16 | 2008-12-01 | Schering Corporation | Antigenos de superficie de celular de mamiferos; reactivos relacionados. |
| ATE412740T1 (de) | 1996-08-16 | 2008-11-15 | Human Genome Sciences Inc | Menschliches alpha-endokin |
| JP2001504325A (ja) | 1996-09-27 | 2001-04-03 | マキシジェン，インコーポレイテッド | 回帰的配列シャフリングおよび選択による遺伝子治療の最適化のための方法 |
| PT939804E (pt) | 1996-10-25 | 2005-11-30 | Human Genome Sciences Inc | Neutroquina alfa |
| JP2001505060A (ja) | 1997-01-14 | 2001-04-17 | ヒューマン ジノーム サイエンシーズ，インコーポレイテッド | 腫瘍壊死因子受容体 ５ |
| KR100570935B1 (ko) | 1997-01-17 | 2006-04-13 | 맥시겐, 인크. | 반복적 서열 재조합에 의한 전세포 및 유기체의 개량 방법 |
| US6326204B1 (en) | 1997-01-17 | 2001-12-04 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
| PT1012274E (pt) | 1997-01-28 | 2007-08-14 | Craig A Rosen | Receptor 4 contendo um domínio de morte (dm4; receptor de morte 4), membro da super-família do ftn e ligação a liart (ap02) |
| ATE418608T1 (de) | 1997-03-18 | 2009-01-15 | Novozymes As | Methode zur herstellung einer bibliothek mittels dna-shuffling |
| WO1998041653A1 (en) | 1997-03-18 | 1998-09-24 | Novo Nordisk A/S | An in vitro method for construction of a dna library |
| US5948653A (en) | 1997-03-21 | 1999-09-07 | Pati; Sushma | Sequence alterations using homologous recombination |
| US6153410A (en) | 1997-03-25 | 2000-11-28 | California Institute Of Technology | Recombination of polynucleotide sequences using random or defined primers |
| CA2292790A1 (en) | 1997-05-30 | 1998-12-03 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptor tr10 |
| CA2295991A1 (en) | 1997-06-11 | 1998-12-17 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptor tr9 |
| WO1999020742A2 (en) | 1997-10-20 | 1999-04-29 | Universita' Degli Studi Di Padova | A packaging cell line producing siv-pseudotyped mlv |
| US6399383B1 (en) | 1997-10-28 | 2002-06-04 | Maxygen, Inc. | Human papilloma virus vectors |
| EP1030861A4 (en) | 1997-10-31 | 2001-09-05 | Maxygen Inc | MODIFICATION OF VIRUSTROPISMIUS AND THE ECONOMIC SPECTRUM BY VIRAL GENOM MIXING |
| US6537746B2 (en) | 1997-12-08 | 2003-03-25 | Maxygen, Inc. | Method for creating polynucleotide and polypeptide sequences |
| FR2773561A1 (fr) | 1998-01-15 | 1999-07-16 | Centre Nat Rech Scient | Utilisation d'une sequence riche en proline pour augmenter le caractere fusogenique d'enveloppes de retrovirus |
| AU3291099A (en) | 1998-02-11 | 1999-08-30 | Maxygen, Inc. | Genetic vaccine vector engineering |
| EP1054973A1 (en) | 1998-02-11 | 2000-11-29 | Maxygen, Inc. | Antigen library immunization |
| US6451304B1 (en) | 1998-03-09 | 2002-09-17 | The Regents Of The University Of California | Method for retrovirus vector production by separated gag and pol expression |
| AU758155B2 (en) | 1998-04-29 | 2003-03-13 | Oklahoma Medical Research Foundation | Construction of retroviral producer cells from adenoviral and retroviral vectors |
| US7001733B1 (en) | 1998-05-12 | 2006-02-21 | Rigel Pharmaceuticals, Inc. | Methods and compositions for screening for modulations of IgE synthesis, secretion and switch rearrangement |
| GB9810752D0 (en) | 1998-05-19 | 1998-07-15 | Glaxo Group Ltd | Cystosine deaminase gene |
| WO1999060110A2 (en) | 1998-05-20 | 1999-11-25 | The University Of Tennessee Research Corporation | Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy |
| IL140100A0 (en) | 1998-06-29 | 2002-02-10 | Phylos Inc | Methods of generating highly diverse libraries |
| US6264940B1 (en) | 1998-08-05 | 2001-07-24 | The Research Foundation Of State University Of New York | Recombinant poliovirus for the treatment of cancer |
| FR2782323B1 (fr) | 1998-08-12 | 2002-01-11 | Proteus | Procede de production in vitro de sequences polynucleotidiques recombinees, banques de sequences et sequences ainsi obtenues |
| IL140441A0 (en) | 1998-09-29 | 2002-02-10 | Maxygen Inc | Shuffling of codon altered genes |
| EP2386646B1 (en) * | 1998-10-01 | 2016-12-21 | University Of Southern California | Gene delivery system and methods of use |
| US6899871B2 (en) * | 1998-10-01 | 2005-05-31 | University Of Southern California | Gene delivery system and methods of use |
| US6576463B1 (en) | 1999-01-15 | 2003-06-10 | The Regents Of The University Of California | Hybrid vectors for gene therapy |
| EP1151409A1 (en) | 1999-01-18 | 2001-11-07 | Maxygen, Inc. | Methods of populating data stuctures for use in evolutionary simulations |
| US6436675B1 (en) | 1999-09-28 | 2002-08-20 | Maxygen, Inc. | Use of codon-varied oligonucleotide synthesis for synthetic shuffling |
| ES2341217T3 (es) | 1999-01-19 | 2010-06-17 | Maxygen, Inc. | Recombinacion de acidos nucleicos mediada por oligonucleotidos. |
| EP1173597A1 (en) | 1999-04-29 | 2002-01-23 | Aarhus University | Expression of heterologous genes from an ires translational cassette in retroviral vectors |
| WO2001004266A1 (en) | 1999-07-08 | 2001-01-18 | The Regents Of The Universty Of California | A lung cancer associated retrovirus, gene delivery vector and methods of use thereof |
| WO2001040488A1 (en) | 1999-11-30 | 2001-06-07 | Novartis Ag | Increased transgene expression in retroviral vectors having scaffold attachment region |
| JP2003520828A (ja) | 2000-01-27 | 2003-07-08 | ジェネティクス インスティテュート，エルエルシー | Ｃｔｌａ４（ｃｄ１５２）に対する抗体、これを含む結合体、およびその使用 |
| AU2001241939A1 (en) | 2000-02-28 | 2001-09-12 | Maxygen, Inc. | Single-stranded nucleic acid template-mediated recombination and nucleic acid fragment isolation |
| US6692736B2 (en) | 2000-03-24 | 2004-02-17 | Cell Genesys, Inc. | Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| WO2002022663A2 (en) | 2000-09-18 | 2002-03-21 | Maxygen, Inc. | Stress resistant retroviruses |
| US20030003565A1 (en) * | 2000-11-27 | 2003-01-02 | Dubensky Thomas W. | Functional lentiviral vector from an MLV-based backbone |
| US7226779B2 (en) | 2001-01-30 | 2007-06-05 | The United States Of America As Represented By The Department Of Health And Human Services | Hybrid adenoviral vector |
| DE10111433A1 (de) | 2001-03-09 | 2002-09-19 | Bundesrepublik Deutschland Let | Replikationskompetente molekulare Klone von porcinem endogenem Retrovirus der Klasse A und Klasse B,abgeleitet von Schweine- und humanen Zellen |
| JP2002335965A (ja) | 2001-05-14 | 2002-11-26 | Japan Science & Technology Corp | 細胞特異的発現複製ベクター |
| DE10143237A1 (de) | 2001-09-04 | 2003-03-20 | Icon Genetics Ag | Herstellung künstlicher interner ribosomaler Eingangsstellenelemente (Ires-Elemente) |
| JP4344858B2 (ja) * | 2001-09-13 | 2009-10-14 | カリフォルニア インスティチュート オブ テクノロジー | 細胞内で抗ウイルス性小ｒｎａ分子を発現させる方法 |
| FR2832424B1 (fr) | 2001-11-20 | 2004-09-24 | Genethon Iii | Plasmide chimere comprenant un genome retroviral replicatif et utilisations |
| US20030121068A1 (en) * | 2001-11-30 | 2003-06-26 | Paul Orchard | Vector encoding suicide and marker constructs |
| CA2474777A1 (en) | 2002-02-01 | 2003-08-07 | Transgene S.A. | Adenoviral vectors for modulating the cellular activities associated with pods |
| US20060147420A1 (en) * | 2004-03-10 | 2006-07-06 | Juan Fueyo | Oncolytic adenovirus armed with therapeutic genes |
| IL165984A0 (en) | 2002-07-17 | 2006-01-15 | Bristol Myers Squibb Co | Transgenic non-huammal cells isolated therefrom and an isolated nucleic acid construct |
| EP1534847B1 (en) * | 2002-09-03 | 2015-10-28 | Oxford Biomedica (UK) Limited | Retroviral vector and stable packaging cell lines |
| JP4672659B2 (ja) | 2003-07-21 | 2011-04-20 | トランジェーヌ、ソシエテ、アノニム | 改善されたシトシンデアミナーゼ活性を有するポリペプチド |
| DE602004031341D1 (de) * | 2003-07-21 | 2011-03-24 | Transgene Sa | Multifunktionelle cytokine |
| US20080227736A1 (en) | 2004-06-03 | 2008-09-18 | Regents Of The University Of California, | Targeting Pseudotyped Retroviral Vectors |
| US20070003522A1 (en) | 2004-07-08 | 2007-01-04 | Albritton Lorraine M | Methods and compositions for improved retroviral gene and drug delivery |
| WO2006048749A1 (en) | 2004-11-04 | 2006-05-11 | Pfizer Products Inc. | Ctla-4 antibody and aromatase inhibitor or combination treatment for breast cancer |
| WO2006058231A2 (en) * | 2004-11-24 | 2006-06-01 | Nanovector Limited | Viral vectors |
| US20060147429A1 (en) * | 2004-12-30 | 2006-07-06 | Paul Diamond | Facilitated cellular reconstitution of organs and tissues |
| US7968698B2 (en) | 2005-05-25 | 2011-06-28 | The Regents Of The University Of California | Optimized core promoters and uses thereof |
| US20070048285A1 (en) * | 2005-08-24 | 2007-03-01 | Christopher Baum | Self-inactivating retroviral vector |
| US20090028842A1 (en) * | 2005-09-30 | 2009-01-29 | Zgene A/S | Dekkera/Brettanomyces Cytosine Deaminases And Their Use |
| AU2006297112B2 (en) * | 2005-10-01 | 2013-04-18 | Charles Stout | Regulatable fusion promoters |
| US8034355B2 (en) | 2005-10-07 | 2011-10-11 | Presidents And Fellows Of Harvard College | Attenuated nonsegmented negative-sense RNA viruses with reduced mRNA cap methyltransferase activity comprising mutations within conserved domain VI of the large polymerase |
| EP1795596A1 (en) * | 2005-12-08 | 2007-06-13 | Ganymed Pharmaceuticals AG | Composition and methods for therapy and diagnosis of cancer |
| EP1969147B1 (en) * | 2006-01-05 | 2014-07-30 | The Ohio State University Research Foundation | microRNA-based methods for the diagnosis of stomach cancer |
| WO2007095201A2 (en) | 2006-02-15 | 2007-08-23 | The Regents Of The University Of California | Pseudotyped retroviral vectors and methods of use thereof |
| EP2004677A2 (en) | 2006-03-17 | 2008-12-24 | Aarhus Universitet | Chimeric viral envelopes |
| WO2007123737A2 (en) * | 2006-03-30 | 2007-11-01 | University Of California | Methods and compositions for localized secretion of anti-ctla-4 antibodies |
| US8329162B2 (en) * | 2006-07-21 | 2012-12-11 | California Institute Of Technology | Targeted gene delivery for dendritic cell vaccination |
| WO2008151633A2 (en) | 2007-06-15 | 2008-12-18 | Skau Aps | Vectors for vaccines against lentivirus infections |
| US9320738B2 (en) | 2008-06-30 | 2016-04-26 | Tocagen Inc. | Formulations of 5-fluorocytosine and uses thereof |
| US8829173B2 (en) | 2008-09-26 | 2014-09-09 | Tocagen Inc. | Recombinant vectors |
| CN102227503B (zh) * | 2008-09-26 | 2015-10-21 | 托卡根公司 | 重组载体 |
| JP5923037B2 (ja) * | 2009-06-17 | 2016-05-24 | トカジェン インコーポレーテッド | 複製可能レトロウイルスベクターの産生細胞 |
| BR112013003135A2 (pt) | 2010-08-13 | 2017-11-07 | Pioneer Hi Bred Int | polinucletídeo e polipeptídeo isolado ou recombinante, construto de ácido nucleico, célula, planta, explante vegetal, semente transgênica, método para produção de célula vegetal para controle de plantas daninhas e para detecção de um polipeptídeo hppd e um polinucleotídeo. |
-
2009
- 2009-09-26 CN CN200980147515.1A patent/CN102227503B/zh not_active Expired - Fee Related
- 2009-09-26 DK DK09820986.9T patent/DK2346995T3/en active
- 2009-09-26 AU AU2009303690A patent/AU2009303690B2/en not_active Ceased
- 2009-09-26 MY MYPI2011001328A patent/MY156333A/en unknown
- 2009-09-26 KR KR1020167016947A patent/KR101870056B1/ko not_active Expired - Fee Related
- 2009-09-26 JP JP2011529292A patent/JP5684130B2/ja not_active Expired - Fee Related
- 2009-09-26 EP EP09820986.9A patent/EP2346995B1/en active Active
- 2009-09-26 EA EA201790824A patent/EA201790824A3/ru unknown
- 2009-09-26 NZ NZ592070A patent/NZ592070A/en not_active IP Right Cessation
- 2009-09-26 JP JP2011529291A patent/JP5771147B2/ja not_active Expired - Fee Related
- 2009-09-26 KR KR1020187016894A patent/KR102025502B1/ko not_active Expired - Fee Related
- 2009-09-26 EP EP18198570.6A patent/EP3502256A3/en not_active Withdrawn
- 2009-09-26 WO PCT/US2009/058510 patent/WO2010045002A2/en not_active Ceased
- 2009-09-26 CA CA2738472A patent/CA2738472A1/en not_active Abandoned
- 2009-09-26 WO PCT/US2009/058512 patent/WO2010036986A2/en not_active Ceased
- 2009-09-26 CN CN200980147509.6A patent/CN102227501B/zh not_active Expired - Fee Related
- 2009-09-26 ES ES09820986T patent/ES2706899T3/es active Active
- 2009-09-26 CN CN201510505943.4A patent/CN105274125A/zh active Pending
- 2009-09-26 MX MX2011003039A patent/MX2011003039A/es active IP Right Grant
- 2009-09-26 ES ES09816967T patent/ES2709481T3/es active Active
- 2009-09-26 BR BRPI0919113A patent/BRPI0919113A2/pt not_active IP Right Cessation
- 2009-09-26 EP EP09816967.5A patent/EP2344648B1/en active Active
- 2009-09-26 EP EP18188075.8A patent/EP3460061A1/en not_active Withdrawn
- 2009-09-26 MX MX2015010159A patent/MX357418B/es unknown
- 2009-09-26 CN CN201510624987.9A patent/CN105624193B/zh not_active Expired - Fee Related
- 2009-09-26 KR KR1020117008744A patent/KR101724162B1/ko not_active Expired - Fee Related
- 2009-09-26 EA EA201170492A patent/EA027693B1/ru not_active IP Right Cessation
-
2011
- 2011-03-18 MX MX2018008440A patent/MX2018008440A/es unknown
- 2011-03-22 ZA ZA2011/02115A patent/ZA201102115B/en unknown
- 2011-03-22 IL IL211847A patent/IL211847A/en active IP Right Grant
- 2011-03-26 US US13/072,705 patent/US8722867B2/en active Active
- 2011-04-25 CO CO11050300A patent/CO6362050A2/es not_active Application Discontinuation
-
2014
- 2014-05-09 US US14/274,556 patent/US10035983B2/en active Active
-
2015
- 2015-01-14 JP JP2015004923A patent/JP5992548B2/ja not_active Expired - Fee Related
- 2015-05-13 JP JP2015097980A patent/JP6062485B2/ja not_active Expired - Fee Related
-
2016
- 2016-08-17 JP JP2016159893A patent/JP6523224B2/ja not_active Expired - Fee Related
- 2016-11-08 IL IL248833A patent/IL248833B/en active IP Right Grant
-
2018
- 2018-07-24 US US16/044,472 patent/US20190185821A1/en not_active Abandoned
-
2019
- 2019-01-13 IL IL264214A patent/IL264214B/en not_active IP Right Cessation
- 2019-04-26 JP JP2019086133A patent/JP2019141088A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012503987A5 (https=) | ||
| US20220195460A1 (en) | Retroviral vector having immune-stimulating activity | |
| JP6523224B2 (ja) | 組換えベクター | |
| EP0832980B1 (en) | Recombinant therapies for infection and hyperproliferative disorders | |
| US8829173B2 (en) | Recombinant vectors | |
| JP6419706B2 (ja) | ミニプロモーターカセットを含むレトロウイルスベクター | |
| JP2018526007A (ja) | ２ａペプチドを含む組換えベクター | |
| JPH10179181A (ja) | 感染および過剰増殖障害の為の組換え療法 | |
| CN105579581A (zh) | 具有优化的a凸出物的重组载体 | |
| JP4343708B2 (ja) | 改良型キメラ糖タンパク質と、類型化されたレンチウイルス | |
| CN116670172A (zh) | 表达免疫检查点抑制剂的癌症特异性反式剪接核酶及其用途 | |
| EP3784278B1 (en) | Foamy viruses and methods of use | |
| US20160222412A1 (en) | Recombinant vector with stabilizing a-loop | |
| CN120647771A (zh) | 一种激活免疫细胞杀伤肿瘤细胞的融合蛋白及其重组病毒和用途 | |
| JP2024526878A (ja) | 調節されたウイルス送達システムおよびその使用 | |
| Duarte | 77. HIV-1 Vector Production Mediated by Rev Protein Transduction | |
| Gentry | T Lymphocyte Based HIV Gene Therapy Strategies | |
| Cornetta | Gene Therapy: Vector Technology and Clinical Applications |